N
← Back to Search
Sponsored

Accelerate Your Clinical Trial Recruitment

Reach thousands of high-intent patients matching your specific inclusion criteria.

Start Campaign
RECRUITING Not applicable ClinicalTrials.gov

A Digital Intervention (ACT on Vaping App) for Vaping Cessation in Young Adult E-Cigarette Users

Sponsor: Fred Hutchinson Cancer Center • ClinicalTrials.gov ID: NCT06909500

Registry updated: 2026-09-08
Ad

Recruiting for Similar Conditions?

Sponsors are looking for patients like you. See if you qualify for compensated research studies.

Check Eligibility →

Description

This clinical trial evaluates a smartphone application (app) called Acceptance and Commitment Therapy (ACT) on Vaping for helping young adults quit using electronic cigarettes (e-cigarettes). E-cigarettes pose numerous risks, particularly to youth and young adults. Addressing the high prevalence of e-cigarette use by young adults requires effective and accessible treatments to support current users to quit. Research shows this group prefers and benefits from newer methods of treatment delivery such as digital interventions. ACT on Vaping is a digital therapeutic intended to deliver behavioral therapy to young adults who vape to motivate and support abstinence from all nicotine and tobacco products. The app contains sessions that promote awareness of cues that trigger tobacco use and teach skills for responding to these triggers in a way that is tailored for the participant's readiness to quit. Receiving access to the ACT on Vaping app may be effective in helping young adults quit vaping.

Interventions

  • Smartphone app (Behavioral)
    Receive access to the ACT on Vaping app
  • Smartphone app (Behavioral)
    Receive access to the ACT on Vaping app
  • Text Message (Other)
    Receive incentivized text messages to access vaping status
  • Text Message (Other)
    Receive intervention text messages
  • Survey Administration (Other)
    Ancillary studies

Eligibility criteria

Inclusion Criteria: * Age 18-30 * Current weekly user of e-cigarette product(s) for the last 30 days * Has a smartphone; either an Android (running version 12 or higher) or iPhone (running iOS version 17 or higher, iPhone 11 or more recent) * Experience downloading and using one or more apps on their smartphone * Have a mobile data plan and/or access to WiFi to support the use of the ACT on Vaping app * Has access to text messaging * Has an email address * United States (US) resident, with a US mailing address * Willing to complete all study procedures * Comfortable reading and writing in English Exclusion Criteria: * Currently using other tobacco cessation treatments at the time of screening, including pharmacotherapy or behavioral support (note: use of these treatment is allowable during trial participation) * Member of the same household as another research participant * Currently in prison * Google voice number as sole phone number, due to its association with fraudulent study entry attempts * Is ineligible per fraud prevention protocol * Employees/family of investigator or study center

Conditions

Nicotine Dependence Tobacco-Related Carcinoma

Locations

  • Fred Hutch/University of Washington Cancer Consortium — Seattle, Washington, United States
Sponsored

Partner with Nurenyx

Showcase your study to thousands of motivated patients matching your criteria.

Learn More

Official Source

Data sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

View Official Record